Loading…
Menarini Group completed the acquisition of Stemline Therapeutics, a US-based biopharmaceutical company.
Menarini Group announced a €150 million investment into a new plant in Italy to significantly increase oral blister capacity, in line with increased demand.
Menarini announced a €150 million investment in a new pharmaceutical manufacturing plant in Italy, described as the most modern and among the largest of the Group.
| Site | Largest | Latest |
|---|---|---|
| Italy, Italy | $170.0M | 2020-06-10 |